Literature DB >> 9811366

Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation.

M Lyte1, J J Varcoe, M T Bailey.   

Abstract

Challenge of animals with infectious microorganisms is well documented to affect a number of behavioral measures through activation of immune-neural mechanisms. In the present study, the ability of an infectious microorganism to directly alter behavioral responses in the absence of an overt immunologic response was examined. Eight-week-old CF-1 male mice were infected orally with the Gram-negative pathogen Campylobacter jejuni in order to establish a subclinical infection that did not result in immune activation. Microbiological examination of cecal contents revealed the presence of C. jejuni in all infected, but not control, animals 1 and 2 days post-oral challenge. Measurement of interleukin-6 (IL-6) levels and peripheral blood leukocyte populations did not reveal the activation of an overt immune response in 1 or 2 day infected animals as compared to controls. Infected mice demonstrated altered levels of anxiety-like behaviors on the elevated plus-maze as compared to controls on Day 2, but not Day 1, as reflected by a significant decrease in exploratory and an increase in nonexploratory behaviors. The anxiogenic effect of a subclinical infection in the absence of an overt immunologic response suggests that the direct activation of neural pathways by microorganisms may play a role in behavior.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811366     DOI: 10.1016/s0031-9384(98)00145-0

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  59 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

2.  Microbiota and host determinants of behavioural phenotype in maternally separated mice.

Authors:  G De Palma; P Blennerhassett; J Lu; Y Deng; A J Park; W Green; E Denou; M A Silva; A Santacruz; Y Sanz; M G Surette; E F Verdu; S M Collins; P Bercik
Journal:  Nat Commun       Date:  2015-07-28       Impact factor: 14.919

Review 3.  Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology.

Authors:  Lisa E Goehler; Mark Lyte; Ronald P A Gaykema
Journal:  Brain Behav Immun       Date:  2007-04-10       Impact factor: 7.217

Review 4.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

5.  I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.

Authors:  Vicente Lorenzo-Zúñiga; Elba Llop; Cristina Suárez; Beatriz Alvarez; Luis Abreu; Jordi Espadaler; Jordi Serra
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  An Overview and Proposed Research Framework for Studying Co-Occurring Mental- and Physical-Health Dysfunction.

Authors:  Sarah L Hagerty; Jarrod M Ellingson; Timothy B Helmuth; L Cinnamon Bidwell; Kent E Hutchison; Angela D Bryan
Journal:  Perspect Psychol Sci       Date:  2019-06-07

7.  The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication.

Authors:  P Bercik; A J Park; D Sinclair; A Khoshdel; J Lu; X Huang; Y Deng; P A Blennerhassett; M Fahnestock; D Moine; B Berger; J D Huizinga; W Kunze; P G McLean; G E Bergonzelli; S M Collins; E F Verdu
Journal:  Neurogastroenterol Motil       Date:  2011-10-11       Impact factor: 3.598

Review 8.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome.

Authors:  Timothy G Dinan; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

9.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

10.  A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome.

Authors:  A Venket Rao; Alison C Bested; Tracey M Beaulne; Martin A Katzman; Christina Iorio; John M Berardi; Alan C Logan
Journal:  Gut Pathog       Date:  2009-03-19       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.